Senomyx (NASDAQ:SNMX)’s share price traded up 0.7% during mid-day trading on Friday . The stock traded as high as $1.45 and last traded at $1.39. 2,500 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 71,313 shares. The stock had previously closed at $1.38.
Separately, ValuEngine raised Senomyx from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd.
The stock has a market cap of $57.00 million, a PE ratio of -45.00 and a beta of 1.42.
Senomyx (NASDAQ:SNMX) last released its earnings results on Thursday, April 26th. The specialty chemicals company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.01). Senomyx had a negative net margin of 5.66% and a negative return on equity of 10.75%. The firm had revenue of $3.11 million during the quarter.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Princeton Capital Management LLC acquired a new position in shares of Senomyx in the 4th quarter valued at $116,000. Quantum Capital Management increased its position in shares of Senomyx by 34.9% in the 1st quarter. Quantum Capital Management now owns 279,813 shares of the specialty chemicals company’s stock valued at $249,000 after acquiring an additional 72,459 shares during the period. Algert Global LLC increased its position in shares of Senomyx by 35.6% in the 4th quarter. Algert Global LLC now owns 487,722 shares of the specialty chemicals company’s stock valued at $634,000 after acquiring an additional 127,934 shares during the period. Renaissance Technologies LLC increased its position in shares of Senomyx by 111.6% in the 4th quarter. Renaissance Technologies LLC now owns 687,800 shares of the specialty chemicals company’s stock valued at $894,000 after acquiring an additional 362,800 shares during the period. Finally, Cowen Prime Services LLC increased its position in shares of Senomyx by 121.4% in the 4th quarter. Cowen Prime Services LLC now owns 737,441 shares of the specialty chemicals company’s stock valued at $959,000 after acquiring an additional 404,290 shares during the period. 29.28% of the stock is currently owned by hedge funds and other institutional investors.
Senomyx Company Profile
Senomyx, Inc discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents.
Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with MarketBeat.com's FREE daily email newsletter.